The FDA has approved Neuronetics’ NeuroStar Advanced Therapy for Mental Health, a transcranial magnetic stimulation system for treatment of anxiety symptoms in adults with major depressive disorder, the company announced in a press release.
In May, the FDA approved the transcranial magnetic stimulation (TMS) system as an adjunct therapy for adults with obsessive compulsive disorder. The non-drug, noninvasive treatment is the first FDA-approved TMS system pioneered for depression, according to the company.
“We’re thrilled to receive FDA clearance to use NeuroStar Advanced